Frequently Asked Questions

iatroX combines real‑time AI‑driven Q&A, stepwise case brainstorming, and quizzes. Unlike many tools that focus on just one aspect, iatroX integrates guidance from a wide range of authoritative UK clinical sources to ensure information is tailored to national guidelines.
iatroX is built on a core knowledge base of official UK clinical guidance that is updated daily. More importantly, iatroX uses an advanced algorithmic approach to evaluate the relevance of this guidance for each query. In cases where a question is highly nuanced, iatroX can autonomously consult a wider body of publicly available peer-reviewed medical research to provide a more complete and synthesized answer, always indicating its sources.
Future integrations with platforms like EMIS and SystmOne are on the roadmap.
iatroX is completely free. There are no hidden fees or subscription costs.
iatroX's knowledge base, which covers a variety of UK national guidance, is synchronised with official sources within 24–48 hours of their publication to ensure clinicians have access to the most current information.
Only minimal logs are kept for performance analytics. No raw audio or identifiable patient data is retained, in compliance with GDPR and NHS data governance.
iatroX was developed as a solo project, born from the desire to streamline access to clinical guidelines using AI technology.
While platforms like ChatGPT, Deepseek, and Gemini are general-purpose AI systems, iatroX is specifically tailored to the healthcare sector. It is built upon a curated knowledge base of UK clinical guidance and delivers evidence-based support, making it uniquely suited as a reference tool for clinical queries.
Yes! iatroX is a MHRA-registered Class I medical device, reference 2025042201417535.
For further questions, please email hello@iatrox.com.
iatroX is a UKCA-marked Class I medical device. Its intended use is to assist UK-based healthcare professionals and students by providing information from clinical guidelines for educational and reference purposes. It is NOT a diagnostic or treatment tool and does not replace clinical judgment.
iatroX is designed, developed, and distributed by iatroX AI Ltd, a company registered in London, United Kingdom.
User feedback is critical for post-market surveillance. If you find any information that seems incorrect or have a safety concern, please email immediately at hello@iatrox.com.